Published in Bipolar Disord on March 01, 2014
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2016) 0.96
Reply to Suppes et al. Bipolar Disord (2014) 0.75
Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am J Psychiatry (2011) 2.35
Bipolar disorder type II revisited. Bipolar Disord (2012) 1.64
Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA (2010) 13.88
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry (2007) 8.11
Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61
Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry (2007) 6.59
The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep (2004) 6.08
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet (2003) 5.75
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA (2003) 5.19
Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry (2010) 4.85
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46
Clinical correlates of inpatient suicide. J Clin Psychiatry (2003) 4.45
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Moderators of treatment outcomes: clinical, research, and policy importance. JAMA (2006) 4.03
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Development of a computerized adaptive test for depression. Arch Gen Psychiatry (2012) 3.77
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60
Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep (2008) 3.44
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry (2010) 2.98
Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatr Serv (2008) 2.68
Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry (2005) 2.53
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med (2005) 2.42
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry (2007) 2.40
The bipolar spectrum. Br J Psychiatry (2007) 2.36
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry (2008) 2.25
Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A (2012) 2.22
Ketamine for depression: where do we go from here? Biol Psychiatry (2012) 2.21
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology (2012) 2.17
Risk factors for the incidence and persistence of suicide-related outcomes: a 10-year follow-up study using the National Comorbidity Surveys. J Affect Disord (2007) 2.16
Development of the CAT-ANX: a computerized adaptive test for anxiety. Am J Psychiatry (2014) 2.16
Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry (2015) 2.15
The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry (2004) 2.13
Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry (2002) 2.12
Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord (2005) 2.12
Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry (2004) 2.11
The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression. J Clin Psychiatry (2013) 2.10
Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet (2011) 2.10
A randomized controlled trial of culturally relevant, brief interpersonal psychotherapy for perinatal depression. Psychiatr Serv (2009) 2.08
Computerized adaptive measurement of depression: a simulation study. BMC Psychiatry (2004) 2.08
Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry (2008) 2.05
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2004) 2.04
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01
Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord (2006) 1.99
Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res (2013) 1.99
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96
Cost of depression in Europe. J Ment Health Policy Econ (2006) 1.96
The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry (2010) 1.94
Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry (2003) 1.94
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther (2009) 1.90
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry (2009) 1.88
Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87
Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry (2002) 1.87
Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biol Psychiatry (2012) 1.85
Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry (2002) 1.84
Placebo in clinical trials for depression: complexity and necessity. JAMA (2002) 1.83
A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med (2006) 1.82
Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry (2007) 1.78
Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res (2007) 1.77
Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med (2002) 1.74
Epidemiological and clinical aspects of bipolar disorders: controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemiol Ment Health (2005) 1.73
Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry (2003) 1.73
Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol (2005) 1.73
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry (2003) 1.71
Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry (2008) 1.71
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology (2006) 1.64
Functional impairment in the remission phase of bipolar disorder. Bipolar Disord (2005) 1.64
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry (2002) 1.63
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry (2007) 1.59
Clinical correlates and familial aggregation of age at onset in bipolar disorder. Am J Psychiatry (2006) 1.58
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry (2008) 1.57
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage (2005) 1.57
Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys (2005) 1.56
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry (2002) 1.55
MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54
Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J Am Geriatr Soc (2007) 1.52
Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. J Clin Psychiatry (2009) 1.51
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep (2007) 1.50
Genome-wide scan and conditional analysis in bipolar disorder: evidence for genomic interaction in the National Institute of Mental Health genetics initiative bipolar pedigrees. Biol Psychiatry (2003) 1.49
Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry (2005) 1.49
Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Am J Psychiatry (2005) 1.48
Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord (2010) 1.48
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom Med (2008) 1.46
Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Arch Gen Psychiatry (2008) 1.45
Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry (2013) 1.43
Waiting to win: elevated striatal and orbitofrontal cortical activity during reward anticipation in euthymic bipolar disorder adults. Bipolar Disord (2012) 1.43
Diagnostic reliability of bipolar II disorder. Arch Gen Psychiatry (2002) 1.42
Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry (2003) 1.42
Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry (2012) 1.41